Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro analysis suggests that SARS-CoV-2 infection differentially modulates cancer-like phenotypes and cytokine expression in colorectal and prostate cancer cells.

Scientific reports - 19 Oct 2024

Serwaa Alberta, Oyawoye Fatima, Owusu Irene Amoakoh, Dosoo Daniel, Manu Aaron Adom, Sobo Augustine Kojo, Fosu Kwadwo, Olwal Charles Ochieng, Quashie Peter Kojo, Aikins Anastasia Rosebud

Abstract excerpt

The coronavirus disease 2019 (COVID-19) reportedly exacerbates cancer outcomes. However, how COVID-19 influences cancer prognosis and development remains poorly understood. Here, we investigated the effect of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2), the etiological agent of COVID-19, on cellular cancer phenotypes the expression of cancer-related markers, and various proinflammatory...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme 2
Share to Cell Movement

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colorectal Neoplasms

Share to COVID-19

Share to Cytokines

Share to Gene Expression Regulation, Neoplastic

Share to Prostatic Neoplasms

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 39427065
DOI: 10.1038/s41598-024-75718-1
PMCID: PMC11490510

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro analysis suggests that SARS-CoV-2 infection differentially modulates cancer-like phenotypes and cytokine expression in colorectal and prostate cancer cells.PMID 39427065Read ↗

Pan-Cancer Analysis Reveals that the SARS-CoV-2 Receptor ACE2 is a Protective Factor for Cancer ProgressionSemantic proximity Read ↗

SARS-CoV-2 infection as a potential risk factor for the development of cancerSemantic proximity Read ↗

The network of SARS-CoV-2—cancer molecular interactions and pathwaysSemantic proximity Read ↗

Pan-cancer analysis of RNA expression of ANGIOTENSIN-CONVERTING ENZYME II (ACE2) and cellular proteases reveals high variability and possible impact on COVID-19 clinical outcomesSemantic proximity Read ↗

The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progressionSemantic proximity Read ↗

COVID-19 and Malignancy: Exploration of the possible genetic and epigenetic interlinks and overview of the vaccination scenario.Semantic proximity Read ↗

Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2.Semantic proximity Read ↗

Genetic Susceptibility of ACE2 and TMPRSS2 in Six Common Cancers and Possible Impacts on COVID-19.Semantic proximity Read ↗

Colorectal Cancer that Highly Express Both ACE2 and TMPRSS2, Suggesting Severe Symptoms to SARS-CoV-2 InfectionSemantic proximity Read ↗

Altered ACE2 and interferon landscape in the COVID-19 microenvironment correlate with the anti-PD-1 response in solid tumorsSemantic proximity Read ↗

Effects of ACE2 and Co-factors on the Mechanism of SARS-CoV-2 Infection Among Colorectal Cancer PatientsSemantic proximity Read ↗

Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.